Breaking: Pfizer Says Covid-19 Vaccine 90% Effective And Markets Jump

Pharmaceutical giant Pfizer has said that its COVID-19 vaccine study has shown that it prevents 90% of infections among those who had no evidence of previous infection. The company has been developing a vaccine with Germany’s BioNTech. No fewer than 43,500 have been participating in the Phase 3 trial.

Pfizer Chairman Albert Bourla said it is a “great day for science and humanity” and will apply for emergency approval to use the vaccine by the end of November. Based on current projections, Pfizer and BioNTech expect to produce up to 50 million doses of vaccine in 2020, and up to 1.3 billion doses in 2021.